Aug 5 (Reuters) – Mironid: * MIRONID RAISES $46 MILLION IN SERIES B FINANCING TO ADVANCE CLINICAL DEVELOPMENT OF ITS TREATMENT FOR RARE KIDNEY DISEASE Source text: Further company coverage: [ ]
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Nasdaq rebounds but remains on track for fourth straight weekly decline
By Colin Barr and Shashwat Chauhan Nov 6 (Reuters) - Technology stocks bounced back on…
Luka Doncic stays hot with 53 points in Lakers' win
VIDEO SHOWS: HIGHLIGHTS OF OS ANGELES LAKERS V PORTLAND TRAIL BLAZERS REGULAR NBA SEASON GAME…
Rugby league-Ponga returns to help New Zealand beat Tonga and reach World Cup final
* Ponga returns three weeks after breaking his arm to help New Zealand reach final…
